Elevated serum levels of IL-6 and other pro-inflammatory cytokines, such as TNF-α and IFN-γ, are hallmarks of systemic inflammation of COVID-19, contributing to disease severity and adverse clinical outcomes [52]. The gene discussed is IFNG; the disease is COVID-19.